342 related articles for article (PubMed ID: 35163688)
1. The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.
Snelson M; Lucut E; Coughlan MT
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163688
[TBL] [Abstract][Full Text] [Related]
2. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
3. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM; Yan SD; Yan SF; Schmidt AM
Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
[TBL] [Abstract][Full Text] [Related]
4. RAGE and its ligands: from pathogenesis to therapeutics.
Jangde N; Ray R; Rai V
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
[TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
[TBL] [Abstract][Full Text] [Related]
6. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
Oczypok EA; Perkins TN; Oury TD
Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
[TBL] [Abstract][Full Text] [Related]
7. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
Yamagishi SI
Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
[TBL] [Abstract][Full Text] [Related]
8. Activation of the receptor for advanced glycation end products and consequences on health.
Wautier MP; Guillausseau PJ; Wautier JL
Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
Bongarzone S; Savickas V; Luzi F; Gee AD
J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
[TBL] [Abstract][Full Text] [Related]
10. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.
Ramasamy R; Yan SF; Schmidt AM
Vascul Pharmacol; 2012; 57(5-6):160-7. PubMed ID: 22750165
[TBL] [Abstract][Full Text] [Related]
11. The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling.
Reed JC; Preston-Hurlburt P; Philbrick W; Betancur G; Korah M; Lucas C; Herold KC
PLoS One; 2020; 15(9):e0236921. PubMed ID: 32986722
[TBL] [Abstract][Full Text] [Related]
12. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
13. Subendothelial Matrix Stiffening by Lysyl Oxidase Enhances RAGE-Mediated Retinal Endothelial Activation in Diabetes.
Chandrakumar S; Santiago Tierno I; Agarwal M; Matisioudis N; Kern TS; Ghosh K
Diabetes; 2023 Jul; 72(7):973-985. PubMed ID: 37058096
[TBL] [Abstract][Full Text] [Related]
14. The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease.
Arivazhagan L; Popp CJ; Ruiz HH; Wilson RA; Manigrasso MB; Shekhtman A; Ramasamy R; Sevick MA; Schmidt AM
Cardiovasc Res; 2024 Feb; 119(18):2813-2824. PubMed ID: 36448548
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation endproducts: from precursors to RAGE: round and round we go.
Ramasamy R; Yan SF; Schmidt AM
Amino Acids; 2012 Apr; 42(4):1151-61. PubMed ID: 20957395
[TBL] [Abstract][Full Text] [Related]
17. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end-products: Biological significance and imaging applications.
Dobrucki IT; Miskalis A; Nelappana M; Applegate C; Wozniak M; Czerwinski A; Kalinowski L; Dobrucki LW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1935. PubMed ID: 37926944
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors.
Singh H; Agrawal DK
Drug Dev Res; 2022 Sep; 83(6):1257-1269. PubMed ID: 35781678
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]